At the operating level, earnings before interest, taxes, depreciation and amortisation (EBITDA) fell 55.4% to Rs 258.3 crore, compared with Rs 579 crore a year ago. Natco Pharma's Q2 FY27 net profit falls 60.8% YoY to Rs 203 crore as revenue drops 29%. Shares slip; second interim dividend declared.